I Hate Dialysis Message Board
Dialysis Discussion => Dialysis: News Articles => Topic started by: okarol on January 19, 2011, 10:25:58 PM
-
Fresenius Medical (NYSE: FMS) Posts Large Volume Increase, Hits $56.44
January 18th, 2011 • View Comments • Filed Under • by ABMN Staff
Shares of Fresenius Medical (NYSE: FMS) saw unusually high trading volume on Tuesday. Approximately 107,899 shares changed hands during mid-day trading, an increase of 33.01% from the previous session. The stock last traded at $56.44.
On a related note, analysts at Zacks Investment Research reiterated a “neutral” rating on shares of Fresenius Medical in a research note to investors on Monday, January 3rd. Separately, analysts at Avondale Partners initiated coverage on shares of Fresenius Medical in a research note to investors on Tuesday, December 14th. They set a “market perform” rating and a $60.00 price target on the stock.
Fresenius Medical Care AG & Co. KGaA (FMC-AG & Co. KGaA) is a kidney dialysis company, operating in both the field of dialysis products and the field of dialysis services. The Company’s dialysis business is vertically integrated, providing dialysis treatment at its own dialysis clinics and supplying these clinics with a range of products. In addition, the Company sells dialysis products to other dialysis service providers. As of December 31, 2009, it provided dialysis treatment to 195,651 patients in 2,553 clinics worldwide located in more than 35 countries. In the United States, it also performs clinical laboratory testing and provides inpatient dialysis services and other services under contract to hospitals. During the year ended December 31, 2009, the Company provided approximately 29.4 million dialysis treatments. During 2009, the Company acquired 73 existing clinics, opened 118 new clinics and sold 26 clinics. During 2009, it acquired production lines from Fresenius SE.
Fresenius Medical (NYSE: FMS) traded down 1.66% during mid-day trading on Tuesday. The stock has a 52 week low of $47.19 and a 52 week high of $64.12. Its 50-day moving average is $57.85 and its 200-day moving average is $58.. The company has a market cap of $17.011 billion and a price-to-earnings ratio of 18.02.
Stay on top of analysts' coverage with American Banking & Market News' daily email newsletter that provides a concise list of analysts’ upgrades, analysts’ downgrades and analysts’ price target changes for each day. Click Here to register.
http://www.americanbankingnews.com/2011/01/18/fresenius-medical-nyse-fms-posts-large-volume-increase-hits-56-44/